cannabinoid CB1 inverse agonists (ACADIA)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namecannabinoid CB1 inverse agonists (ACADIA)
Drug Alias NameCB1 inverse agonists (ACADIA)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor inverse agonists
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsCognition DisordersSubstance-Related DisordersObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAcadia Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAcadia Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsCognition DisordersSubstance-Related DisordersObesity

Other Information

ATC CodeN/A
Related LinksN/A